The Motley Fool 对 $OSCR 的判断变化

频道资料 →频道引用的来源:AXON management、Alphabet management on return on invested capital、the company共 2 条

The Motley Fool 自 2026-11-10 起在 2 个视频里谈过 $OSCR。

2026-11-13
《5 Stocks Set to Soar in 2027》
AI 摘要 · Oscar Health的未来方向看起来有前景,但说话者一直未入场,因为华盛顿在ACA及其资金方面的决定——不在公司控制范围内——可能深刻影响其业务并引发波动,而他不知道这些决定将如何收场。他曾考虑建立一个小仓位,在经历一次大幅下跌后可能转为完整仓位;OSCR已列入他2027年的关注名单。

我认为这大概率是未来的方向,对 Oscar Health 是好事。我作为股东唯一无法支持 Oscar Health 的原因,是我在监管环境中看到的风险。

think that's probably the future direction , and it's good for Oscar Health . The only reason I couldn't support Oscar Health as a shareholder is the risks I see in the regulatory landscape.

我只担心立法者可能会做什么,这将对 Oscar Health 的业务产生重大而深远的影响,而这完全不在公司的控制范围内,也就是华盛顿决定怎么做。

I am only concerned about what the legislators might do, which will have a significant and profound impact on Oscar Health's business, and this is something completely out of the company's control, i.e., what Washington decides to do.

2026-11-10看涨
《Stock Market Update: Rising Rates & Falling Stocks》
AI 摘要 · OSCR又交出一个好季度并上调全年指引:收入从187–190亿美元上调至190–193亿美元,经营利润展望上调,医疗赔付率预计为80.5–81.5%;管理层称正朝着最强财年迈进,公司盈利且增长迅速。说话者看好OSCR的方向,提到Mark的领导力和有吸引力的ICRA市场模式,但尚未持股,并希望自己在20美元左右买入过。

他们上周确实发布了财报。又是一个相当不错的季度。让我想想我记不记得。我觉得他们可能又上调了指引。对,我觉得展望被上调了。他们现在预计营收在190亿到193亿美元之间,高于此前的187亿到190亿美元。

全年展望中,运营利润也上调了。医疗成本率,医疗赔付率现在预计在80.5到81.5之间,所以这方面略有改善。公司表示,他们有望实现历史上最强的财务表现。他们确实在盈利,而且增长相当快。

They they did report last week. It was another pretty good quarter. Let me see if I can remember. Um I think they they might have raised guidance again. Yeah, I think outlook was was raised.

Um they're now looking at between 19 to 19.3 billion in revenue. That's up from $18.7 to19 billion. Uh earnings from operations is also up for the full full year outlook. Medical cost rat medical loss loss ratio is now expected to be between 80.5 to 81.5.

So slight improvement there. Um co said they're on track to deliver the strongest year of financial performance in their history. They actually generate profit. They're growing quite quickly.